Emergency Use Authorization Requirements May Offer FDA Better Window Into Medication Errors

 
• By Sarah Karlin-Smith
Regeneron COVID-19 antibodies and Moderna COVID-19 vaccine
Similar packaging lead to mix-ups of Regeneron’s COVID-19 antibodies (left) and Moderna’s COVID-19 vaccine. • Source: FDA

More from Drug Safety

More from Pink Sheet